Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-02

Clinical Trial Update: Atacand (Candesartan) Real Life Study

View source ↗

Summary

A real-world study of Atacand (candesartan) in hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atacand (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Status: COMPLETED